Weiqing Wang
Welcome,         Profile    Billing    Logout  
 7 Trials 
9 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ning, Guang
NCT06531512: Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers

Recruiting
2/3
120
RoW
Xianglei Tangzu Gao, Vehicle Cream
Oneness Biotech Co., Ltd.
Diabetic Foot Ulcer
12/25
03/26
NCT06042764: SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients

Recruiting
2
150
RoW
SA55 Injection
Sinovac Life Sciences Co., Ltd.
Infection of Upper Respiratory Tract Caused by 2019-nCoV
03/24
08/24
NCT06141369: Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Recruiting
N/A
21
RoW
individualized mRNA neoantigen vaccine (mRNA-0523-L001)
Shanghai Jiao Tong University School of Medicine
Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma, Pancreatic Neuroendocrine Tumor
06/25
12/25
BPROAD, NCT03808311: Blood Pressure Control Target in Diabetes

Completed
N/A
12821
RoW
Treatment strategy regarding different systolic BP goals
Shanghai Jiao Tong University School of Medicine
Blood Pressure Control Target in Diabetes
05/24
09/24
GOCY, NCT01084967: Genetics of Obesity in Chinese Youngs

Recruiting
N/A
8000
RoW
Shanghai Jiao Tong University School of Medicine
Obesity, Metabolic Syndrome
04/26
04/26
CDR-MMC, NCT03811470: China Diabetes Registry by Metabolic Management Center

Recruiting
N/A
1000000
RoW
Standard diabetes management model in each MMC center
Guang Ning
Type 2 Diabetes Mellitus, Type1 Diabetes Mellitus, Monogenetic Diabetes, Pancreatogenic Diabetes, Drug-Induced Diabetes Mellitus, Other Forms of Diabetes Mellitus
05/37
05/39
NCT04240652: The Diabetic Retinopathy Screening, Prevention and Control Program

Recruiting
N/A
500000
RoW
Shanghai Jiao Tong University School of Medicine
Diabetic Retinopathy
06/38
06/40
NCT05489874: A Real-world Retrospective Study of Disease Outcomes in Non-severe COVID-19 Patient

Recruiting
N/A
2000
RoW
Shanghai Vinnerna Biosciences Co., Ltd.
COVID-19 Patient
12/24
12/24
NCT05387304: A Follow-up Study of Asymptomatic Infections and Diagnosed Patients With Covid-19 in Shanghai

Recruiting
N/A
250000
RoW
Ruijin Hospital
COVID-19
05/32
05/32

Download Options